TrialArthritis research & therapy2026
Safety, tolerability, pharmacokinetics, and pharmacodynamics of ABP-671 in healthy participants and patients with hyperuricemia and gout: a proof-of-concept study.
Jin Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.